The effect of dupilumab on lung function parameters in patients with oral corticosteroid-dependent severe asthma
Respiratory Medicine: X · 2020
DOI: 10.1016/j.yrmex.2019.100010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Respiratory Medicine: X, 2020. Verfasst von Klaus F. Rabe und 11 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sanofi, Regeneron Pharmaceuticals.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Sanofi
- Regeneron Pharmaceuticals
Zitieren
APA
Rabe, K. F., Nair, P., Maspero, J. F., Castro, M., Rice, M. S., Deniz, Y., Rowe, P., Staudinger, H. W., Pirozzi, G., Akinlade, B., Graham, N. M., & Teper, A. (2020). The effect of dupilumab on lung function parameters in patients with oral corticosteroid-dependent severe asthma. Respiratory Medicine: X. https://doi.org/10.1016/j.yrmex.2019.100010
Vancouver
Rabe KF, Nair P, Maspero JF, Castro M, Rice MS, Deniz Y, et al. The effect of dupilumab on lung function parameters in patients with oral corticosteroid-dependent severe asthma. Respiratory Medicine: X. 2020. doi:10.1016/j.yrmex.2019.100010
BibTeX
@article{Rabe2020,
author = {Rabe, Klaus F. and Nair, Parameswaran and Maspero, Jorge F. and Castro, Mario and Rice, Megan S. and Deniz, Yamo and Rowe, Paul and Staudinger, Heribert W. and Pirozzi, Gianluca and Akinlade, Bolanle and Graham, Neil M.H. and Teper, Ariel},
title = {The effect of dupilumab on lung function parameters in patients with oral corticosteroid-dependent severe asthma},
journal = {Respiratory Medicine: X},
year = {2020},
doi = {10.1016/j.yrmex.2019.100010}
}
EUVIMED